다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics Inc (LSTA) 뉴스

LSTA

Lisata Therapeutics (LSTA)

Lisata Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LSTA

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/28	06:05	GlobeNewswire Inc.	Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update	NASDAQ:LSTA	Lisata Therapeutics Inc
2025/02/20	22:00	GlobeNewswire Inc.	Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025	NASDAQ:LSTA	Lisata Therapeutics Inc
2025/02/05	22:30	GlobeNewswire Inc.	Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference	NASDAQ:LSTA	Lisata Therapeutics Inc
2025/01/23	22:00	GlobeNewswire Inc.	Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma	NASDAQ:LSTA	Lisata Therapeutics Inc
2025/01/22	22:00	GlobeNewswire Inc.	Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma	NASDAQ:LSTA	Lisata Therapeutics Inc
2025/01/15	22:30	GlobeNewswire Inc.	Lisata Therapeutics to Present at the 2025 Sequire Investor Summit	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/12/10	22:30	GlobeNewswire Inc.	Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/12/03	22:30	GlobeNewswire Inc.	Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/11/19	22:30	GlobeNewswire Inc.	Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/11/13	06:05	GlobeNewswire Inc.	Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/11/06	23:23	GlobeNewswire Inc.	Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/11/06	22:30	GlobeNewswire Inc.	Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/10/31	21:30	GlobeNewswire Inc.	Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/10/28	21:30	GlobeNewswire Inc.	Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/10/03	21:00	GlobeNewswire Inc.	Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/09/17	21:00	GlobeNewswire Inc.	Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/09/09	21:00	GlobeNewswire Inc.	Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/09/05	21:00	GlobeNewswire Inc.	Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/08/13	05:05	GlobeNewswire Inc.	Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/08/05	21:00	GlobeNewswire Inc.	Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/07/18	21:00	GlobeNewswire Inc.	Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/07/16	21:00	GlobeNewswire Inc.	Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/07/10	21:00	GlobeNewswire Inc.	Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/06/13	21:30	GlobeNewswire Inc.	Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/05/28	21:30	GlobeNewswire Inc.	Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/05/20	21:30	GlobeNewswire Inc.	Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/05/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/05/10	05:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/05/10	05:05	GlobeNewswire Inc.	Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:LSTA	Lisata Therapeutics Inc
2024/05/08	21:00	GlobeNewswire Inc.	Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events	NASDAQ:LSTA	Lisata Therapeutics Inc

검색 관련기사 보기:NASDAQ:LSTA

1 2 3 다음 >>

JP Morgan Chase

US Dollar vs Yen

Energy Select Sector SPDR

Invesco QQQ Trust Series 1

American Express

Health Care Select Sector

Verizon Communications

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관